Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractInterferon-beta (IFN-beta) is a pleiotropic cytokine that is known to modulate the immune response in multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system (CNS). Spontaneous remyelination and repair mechanisms in MS are mostly insufficient and contribute to clinical disability. Here, we investigated whether IFN-beta has a potential in modifying the extent of de- and remyelination in a toxic model of CNS demyelination induced by the copper chelator cuprizone. IFN-beta deficient (k/o) mice showed an accelerated spontaneous remyelination. However, the amount of remyelination after 6 weeks did not differ between the two groups. Demyelination in IFN-beta k/o mice was paralleled by a diminished astrocytic and microglia response as compared with wildtype controls, whereas the accelerated remyelination was paralleled by an increased number of oligodendrocyte precursor cells (OPC) within the demyelinated lesion at the beginning of the remyelination phase. We hypothesize that the absence of IFN-beta leads to more efficient recruitment and proliferation of OPC already during demyelination, thus allowing early remyelination. These results demonstrate that IFN-beta is able to alter remyelination in the absence of an immune-mediated demyelination.
CitationLack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination. 2007, 114 (6):587-96 Acta Neuropathol.
AffiliationDepartment of Neurology, Medical School Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
The following license files are associated with this item:
- Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant.
- Authors: Schmidt H, Raasch J, Merkler D, Klinker F, Krauss S, Brück W, Prinz M
- Issue date: 2009 Apr
- Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
- Authors: Lindner M, Fokuhl J, Linsmeier F, Trebst C, Stangel M
- Issue date: 2009 Apr 3
- The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.
- Authors: Matsushima GK, Morell P
- Issue date: 2001 Jan
- The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination.
- Authors: Lindner M, Trebst C, Heine S, Skripuletz T, Koutsoudaki PN, Stangel M
- Issue date: 2008 Aug 1
- Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination.
- Authors: Plant SR, Arnett HA, Ting JP
- Issue date: 2005 Jan 1